Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31921679)

  • 1. Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma.
    Frandsen S; Broholm H; Larsen VA; Grunnet K; Møller S; Poulsen HS; Michaelsen SR
    Front Oncol; 2019; 9():1425. PubMed ID: 31921679
    [No Abstract]   [Full Text] [Related]  

  • 2. Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database.
    Frandsen J; Orton A; Jensen R; Colman H; Cohen AL; Tward J; Shrieve DC; Suneja G
    J Neurosurg; 2018 Apr; 128(4):1133-1138. PubMed ID: 28621623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gliosarcoma: an audit from a single institution in India of 24 post-irradiated cases over 15 years.
    Kumar P; Singh S; Kumar P; Krishnani N; Datta NR
    J Cancer Res Ther; 2008; 4(4):164-8. PubMed ID: 19052388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
    Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
    J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
    Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
    J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
    Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
    J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and survival characteristics of primary and secondary gliosarcoma patients.
    Amer A; Khose S; Alhasan H; Pokhylevych H; Fuller G; Chasen N; de Groot J; Johnson JM
    Clin Neurol Neurosurg; 2022 Mar; 214():107146. PubMed ID: 35101778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
    Smith DR; Wu CC; Saadatmand HJ; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; Wang SH; Canoll P; McKhann GM; Wang TJC
    J Neurooncol; 2018 Apr; 137(2):303-311. PubMed ID: 29264835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Intracranial Gliosarcoma: Is It Really a Variant of Glioblastoma? An Update of the Clinical, Radiological, and Biomolecular Characteristics.
    La Torre D; Della Torre A; Lo Turco E; Longo P; Pugliese D; Lacroce P; Raudino G; Romano A; Lavano A; Tomasello F
    J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study.
    Costa BM; Caeiro C; Guimarães I; Martinho O; Jaraquemada T; Augusto I; Castro L; Osório L; Linhares P; Honavar M; Resende M; Braga F; Silva A; Pardal F; Amorim J; Nabiço R; Almeida R; Alegria C; Pires M; Pinheiro C; Carvalho E; Lopes JM; Costa P; Damasceno M; Reis RM
    Oncol Rep; 2010 Jun; 23(6):1655-62. PubMed ID: 20428822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gliosarcoma: a clinical study.
    Lutterbach J; Guttenberger R; Pagenstecher A
    Radiother Oncol; 2001 Oct; 61(1):57-64. PubMed ID: 11578729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary versus secondary gliosarcoma: a systematic review and meta-analysis.
    Vuong HG; Dunn IF
    J Neurooncol; 2022 Aug; 159(1):195-200. PubMed ID: 35768633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.
    Cachia D; Kamiya-Matsuoka C; Mandel JJ; Olar A; Cykowski MD; Armstrong TS; Fuller GN; Gilbert MR; De Groot JF
    J Neurooncol; 2015 Nov; 125(2):401-10. PubMed ID: 26354773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study.
    Yu Z; Zhou Z; Xu M; Song K; Shen J; Zhu W; Wei L; Xu H
    Comput Math Methods Med; 2023; 2023():1553408. PubMed ID: 36756387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy plus concomitant temozolomide in primary gliosarcoma.
    Adeberg S; Bernhardt D; Harrabi SB; Diehl C; Koelsche C; Rieken S; Unterberg A; von Deimling A; Debus J
    J Neurooncol; 2016 Jun; 128(2):341-8. PubMed ID: 27025857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral gliosarcoma: Analysis of 16 patients and review of literature.
    Singh G; Das KK; Sharma P; Guruprasad B; Jaiswal S; Mehrotra A; Srivastava AK; Sahu RN; Jaiswal AK; Behari S
    Asian J Neurosurg; 2015; 10(3):195-202. PubMed ID: 26396606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of O6-methylguanine-DNA methyltransferase (MGMT) protein expression as prognostic marker in glioblastoma patients treated with radiation therapy with concomitant and adjuvant Temozolomide.
    Younis SG; Khedr RA; El-Shorbagy SH
    J Egypt Natl Canc Inst; 2016 Mar; 28(1):23-30. PubMed ID: 26682634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chasing a rarity: a retrospective single-center evaluation of prognostic factors in primary gliosarcoma.
    Dejonckheere CS; Böhner AMC; Koch D; Schmeel LC; Herrlinger U; Vatter H; Schneider M; Schuss P; Giordano FA; Köksal MA
    Strahlenther Onkol; 2022 May; 198(5):468-474. PubMed ID: 34939129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma.
    Jin MC; Liu EK; Shi S; Gibbs IC; Thomas R; Recht L; Soltys SG; Pollom EL; Chang SD; Hayden Gephart M; Nagpal S; Li G
    Front Oncol; 2020; 10():337. PubMed ID: 32219069
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database.
    Shieh LT; Ho CH; Guo HR; Huang CC; Ho YC; Ho SY
    Front Neurol; 2021; 12():659921. PubMed ID: 34899553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.